Homburger advised EQT on the sale of an additional 10% in Galderma to L’Oréal for an undisclosed amount. The transaction, currently subject to customary regulatory approvals, involved a consortium of sellers led by EQT
Tags :Slider
Software investor Main Capital Partners acquired a majority stake in Swiss software solutions provider Polypoint. In connection with the deal, Bär & Karrer advised the buyer, Pestalozzi represented the selling part, while Baker McKenzie
Lenz & Staehelin advised Swiss cybersecurity firm Monti Stampa Furrer & Partners (MSF Partners) and its shareholders in connection with the company’s sale to Stockholm-based Allurity, also active in the cibersecurity sector. About MSF
Bär & Karrer advised technology company TeamSystem, a specialist in digital solutions for management of businesses and professionals, on the acquisition of Swiss-based Arca24.com , a software house specialised in the development and commercialization
Baker McKenzie advised the majority shareholders of the Citieffe Group, including private equity firm Archimed, on the sale of their entire stake in Medistream – a Swiss company that owns Italian medical device manufacturer Citieffe SRL
Niederer Kraft Frey (NKF) advised Climate Impulse – a project for sustainable aviation led by Swiss explorer Bertrand Piccard and composite engineer Raphaël Dinelli – on its partnership agreement with Orange. The context Climate Impulse’s
Bär & Karrer advised Amadeus Capital, a Geneva-based wealth and asset manager, in connection with the acquisition of the activities of Amasus Investment, a wealth management company with headquarters in Zurich. The Bä
Niederer Kraft Frey (NKF) advised the shareholders of HR-technology specialist Kollabo on the company’s sale to Enovetic. The parties Headquartered in Zurich, Kollabo operates a digital engagement platform for job seekers and temporary job
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.
Swiss-based Mageba Group completed a refinancing operation via a syndicated loan with a banking consortium led by UBS Switzerland. In connection with the deal, Niederer Kraft Frey (NKF) advised UBS Switzerland, as well as the
